BIOA Announcement: Kessler Topaz Meltzer & Check, LLP Encourages BioAge Labs, Inc. (BIOA) Investors to Contact the Firm About Securities Fraud Class Action LawsuitRADNOR, PA - February 4, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge LabsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BioAge To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge, AstraZeneca, FTAI, and Revance and Encourages Investors to Contact the FirmNEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BioAge Labs, Inc. (
NASDAQBIOA), AstraZeneca PLC
NASDAQ: AZNNASDAQAZN)
(NASDAQ:FTAINASDAQFTAI
, and Revance Therapeutics, Inc. (NASDAQ:RVNCNASDAQ
). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
BIOA Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. (BIOA)RADNOR, PA - February 2, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
BIOA Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Shareholders of Deadline in Securities Fraud Class Action LawsuitRADNOR, PA - January 31, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge, Caribou, FTAI, and Revance and Encourages Investors to Contact the FirmNEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BioAge Labs, Inc. (
NASDAQBIOA), Caribou Biosciences, Inc.
NASDAQ: CRBUNASDAQCRBU)
(NASDAQ:FTAINASDAQFTAI
, and Revance Therapeutics, Inc. (NASDAQ:RVNCNASDAQ
). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Class Action Reminder for BIOA Investors: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Securities Fraud Class Action LawsuitRADNOR, PA - January 29, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge LabsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BioAge To Contact Him Directly To Discuss Their Options
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform ProgramsAdvancement of next-generation APJ agonists with discontinuation of azelaprag
BIOA Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors that a Securities Fraud Class Action Lawsuit Has Been FiledRADNOR, PA - January 27, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Investors of Important Deadline in Securities Fraud Class Action LawsuitSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Investors of Important Deadline in Securities Fraud Class Action LawsuitRADNOR, PA - January 25, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
BIOA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BIOA Investors With Losses to Contact the FirmSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BIOA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BIOA Investors With Losses to Contact the FirmRADNOR, PA - January 23, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (
NASDAQBIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or about September 26, 2024 (the “Class Period”). The lead plaintiff deadline is March 10, 2025.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge and Revance and Encourages Investors to Contact the FirmNEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BioAge Labs, Inc. (
NASDAQBIOA) and Revance Therapeutics, Inc.
NASDAQ:RVNCNASDAQRVNC)
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge LabsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BioAge To Contact Him Directly To Discuss Their Options
